Efficacy and Safety of Yanggan Jian in Hepatitis B Virus-related Decompensated Cirrhosis: A Randomized, Double-blind, Controlled Trial

BACKGROUND AND AIMS: The aim was to evaluate the efficacy and safety of Yanggan Jian (YGJ) in HBV-infected patients with decompensated cirrhosis. METHODS: This randomized, double-blind controlled trial enrolled 160 patients with HBV-related decompensated cirrhosis who were already receiving or about...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Zhao, Chaoqun, Yao, Weili, Liu, Wei, Zhang, Hua, Mu, Yongping, Cai, Hong, Xue, Dongying, Wang, Chengbao, Wang, Wan’e, Lin, Yuehong, Chen, Jiamei, Liu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647101/
https://www.ncbi.nlm.nih.gov/pubmed/36406328
http://dx.doi.org/10.14218/JCTH.2021.00451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647101/
https://www.ncbi.nlm.nih.gov/pubmed/36406328
http://dx.doi.org/10.14218/JCTH.2021.00451

Ejemplares similares